EDITORIAL

Contemporary considerations for risk stratification, sudden death and prevention in hypertrophic cardiomyopathy

B J Maron

Correspondence to:
Correspondence to:
Barry J Maron, MD, Minneapolis Heart Institute Foundation, 920 E 28th Street, Suite 60, Minneapolis, MN 55407, USA;
hcm.maron@mhif.org

---

For patients with hypertrophic cardiomyopathy, the likelihood of receiving primary prevention for sudden death with an ICD may depend in part on the country of residence

---

Keywords: sudden death; hypertrophic cardiomyopathy; risk stratification

The first 150 words of the full text of this article appear below.

Sudden death has been the most devastating, unpredictable and recognisable complication of hypertrophic cardiomyopathy (HCM), since the modern description of the disease by Teare over 40 years ago.¹ HCM is now recognised as the most common cause of sudden cardiac death in young people, including trained athletes,^2,3 although only a minority of all HCM patients are susceptible to the risk of sudden death (perhaps 10–15%).⁴ Nevertheless, the identification of this patient subset has been a priority, and the subject of a considerable body of literature.^3–10 Because of the power and availability of the implantable cardioverter-defibrillator (ICD) for both primary and secondary prevention of sudden death, and its recent application to HCM,⁹ it now more important than ever to identify those patients within this broad disease spectrum who are at high risk for a catastrophic event.

Defining reliable clinical markers for sudden death, and isolating the minority of HCM patients who . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Ahmed, I., Smalley, S. J, Zhu, D. W X, Dahiya, R., House, C. M, Nelson, W. B (2009). Sudden cardiac arrest in apical hypertrophic cardiomyopathy. BMJ Case Reports 2009: bcr0420091753-bcr0420091753 [Abstract] [Full Text]  
• Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N.A. M. III, Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., Hlatky, M. A., Newby, L. K., Page, R. L., Schoenfeld, M. H., Silka, M. J., Stevenson, L. W., Sweeney, M. O. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51: e1-e62 [Full Text]  
• Writing Committee Members, , Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N.A. M. III, Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., Hlatky, M. A., Newby, L. K., Page, R. L., Schoenfeld, M. H., Silka, M. J., Stevenson, L. W., Sweeney, M. O. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117: e350-e408 [Full Text]  
• Adabag, A. S., Maron, B. J., Appelbaum, E., Harrigan, C. J., Buros, J. L., Gibson, C. M., Lesser, J. R., Hanna, C. A., Udelson, J. E., Manning, W. J., Maron, M. S. (2008). Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance. J Am Coll Cardiol 51: 1369-1374 [Abstract] [Full Text]